207 related articles for article (PubMed ID: 22103913)
1. Characterization of a novel PTEN mutation in MDA-MB-453 breast carcinoma cell line.
Singh G; Odriozola L; Guan H; Kennedy CR; Chan AM
BMC Cancer; 2011 Nov; 11():490. PubMed ID: 22103913
[TBL] [Abstract][Full Text] [Related]
2. PTEN lipid phosphatase activity and proper subcellular localization are necessary and sufficient for down-regulating AKT phosphorylation in the nucleus in Cowden syndrome.
He X; Saji M; Radhakrishnan D; Romigh T; Ngeow J; Yu Q; Wang Y; Ringel MD; Eng C
J Clin Endocrinol Metab; 2012 Nov; 97(11):E2179-87. PubMed ID: 22962422
[TBL] [Abstract][Full Text] [Related]
3. Germline and somatic cancer-associated mutations in the ATP-binding motifs of PTEN influence its subcellular localization and tumor suppressive function.
Lobo GP; Waite KA; Planchon SM; Romigh T; Nassif NT; Eng C
Hum Mol Genet; 2009 Aug; 18(15):2851-62. PubMed ID: 19457929
[TBL] [Abstract][Full Text] [Related]
4. Differential expression of novel naturally occurring splice variants of PTEN and their functional consequences in Cowden syndrome and sporadic breast cancer.
Agrawal S; Eng C
Hum Mol Genet; 2006 Mar; 15(5):777-87. PubMed ID: 16436456
[TBL] [Abstract][Full Text] [Related]
5. Cowden syndrome-associated germline SDHD variants alter PTEN nuclear translocation through SRC-induced PTEN oxidation.
Yu W; He X; Ni Y; Ngeow J; Eng C
Hum Mol Genet; 2015 Jan; 24(1):142-53. PubMed ID: 25149476
[TBL] [Abstract][Full Text] [Related]
6. Inherited mutations in PTEN that are associated with breast cancer, cowden disease, and juvenile polyposis.
Lynch ED; Ostermeyer EA; Lee MK; Arena JF; Ji H; Dann J; Swisshelm K; Suchard D; MacLeod PM; Kvinnsland S; Gjertsen BT; Heimdal K; Lubs H; Møller P; King MC
Am J Hum Genet; 1997 Dec; 61(6):1254-60. PubMed ID: 9399897
[TBL] [Abstract][Full Text] [Related]
7. Germline PTEN promoter mutations and deletions in Cowden/Bannayan-Riley-Ruvalcaba syndrome result in aberrant PTEN protein and dysregulation of the phosphoinositol-3-kinase/Akt pathway.
Zhou XP; Waite KA; Pilarski R; Hampel H; Fernandez MJ; Bos C; Dasouki M; Feldman GL; Greenberg LA; Ivanovich J; Matloff E; Patterson A; Pierpont ME; Russo D; Nassif NT; Eng C
Am J Hum Genet; 2003 Aug; 73(2):404-11. PubMed ID: 12844284
[TBL] [Abstract][Full Text] [Related]
8. Germline epigenetic regulation of KILLIN in Cowden and Cowden-like syndrome.
Bennett KL; Mester J; Eng C
JAMA; 2010 Dec; 304(24):2724-31. PubMed ID: 21177507
[TBL] [Abstract][Full Text] [Related]
9. Germline mutations in the PTEN gene in Israeli patients with Bannayan-Riley-Ruvalcaba syndrome and women with familial breast cancer.
Figer A; Kaplan A; Frydman M; Lev D; Paswell J; Papa MZ; Goldman B; Friedman E
Clin Genet; 2002 Oct; 62(4):298-302. PubMed ID: 12372056
[TBL] [Abstract][Full Text] [Related]
10. A novel deleterious PTEN mutation in a patient with early-onset bilateral breast cancer.
Pradella LM; Evangelisti C; Ligorio C; Ceccarelli C; Neri I; Zuntini R; Amato LB; Ferrari S; Martelli AM; Gasparre G; Turchetti D
BMC Cancer; 2014 Feb; 14():70. PubMed ID: 24498881
[TBL] [Abstract][Full Text] [Related]
11. Cowden syndrome-affected patients with PTEN promoter mutations demonstrate abnormal protein translation.
Teresi RE; Zbuk KM; Pezzolesi MG; Waite KA; Eng C
Am J Hum Genet; 2007 Oct; 81(4):756-67. PubMed ID: 17847000
[TBL] [Abstract][Full Text] [Related]
12. Differential regulation of PTEN expression by androgen receptor in prostate and breast cancers.
Wang Y; Romigh T; He X; Tan MH; Orloff MS; Silverman RH; Heston WD; Eng C
Oncogene; 2011 Oct; 30(42):4327-38. PubMed ID: 21532617
[TBL] [Abstract][Full Text] [Related]
13. Molecular apocrine differentiation is a common feature of breast cancer in patients with germline PTEN mutations.
Banneau G; Guedj M; MacGrogan G; de Mascarel I; Velasco V; Schiappa R; Bonadona V; David A; Dugast C; Gilbert-Dussardier B; Ingster O; Vabres P; Caux F; de Reynies A; Iggo R; Sevenet N; Bonnet F; Longy M
Breast Cancer Res; 2010; 12(4):R63. PubMed ID: 20712882
[TBL] [Abstract][Full Text] [Related]
14. A novel mutation of the PTEN gene in a Japanese patient with Cowden syndrome and bilateral breast cancer.
Tate G; Suzuki T; Endo Y; Mitsuya T
Cancer Genet Cytogenet; 2008 Jul; 184(1):67-71. PubMed ID: 18558293
[TBL] [Abstract][Full Text] [Related]
15. Naturally occurring germline and tumor-associated mutations within the ATP-binding motifs of PTEN lead to oxidative damage of DNA associated with decreased nuclear p53.
He X; Ni Y; Wang Y; Romigh T; Eng C
Hum Mol Genet; 2011 Jan; 20(1):80-9. PubMed ID: 20926450
[TBL] [Abstract][Full Text] [Related]
16. Male breast cancer in Cowden syndrome patients with germline PTEN mutations.
Fackenthal JD; Marsh DJ; Richardson AL; Cummings SA; Eng C; Robinson BG; Olopade OI
J Med Genet; 2001 Mar; 38(3):159-64. PubMed ID: 11238682
[TBL] [Abstract][Full Text] [Related]
17. Analysis of PTEN gene mutations in Korean patients with Cowden syndrome and polyposis syndrome.
Kim DK; Myung SJ; Yang SK; Hong SS; Kim KJ; Byeon JS; Lee GH; Kim JH; Min YI; Lee SM; Jeong JY; Song K; Jung SA
Dis Colon Rectum; 2005 Sep; 48(9):1714-22. PubMed ID: 16007494
[TBL] [Abstract][Full Text] [Related]
18. PTEN: one gene, many syndromes.
Eng C
Hum Mutat; 2003 Sep; 22(3):183-98. PubMed ID: 12938083
[TBL] [Abstract][Full Text] [Related]
19. [Mutations of tumor suppressor gene PTEN mutations in hepatocellular carcinoma and its implications in tumor proliferation and apoptosis].
Guo SP; Wang L; Wang WL; Li QL; Wang WY; Zhang J
Zhonghua Bing Li Xue Za Zhi; 2006 Aug; 35(8):467-72. PubMed ID: 17069699
[TBL] [Abstract][Full Text] [Related]
20. A novel loss-of-function mutation (N48K) in the PTEN gene in a Spanish patient with Cowden disease.
Vega A; Torres J; Torres M; Cameselle-Teijeiro J; Macia M; Carracedo A; Pulido R
J Invest Dermatol; 2003 Dec; 121(6):1356-9. PubMed ID: 14675182
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]